Recruiting

JACARDI: A eHealth and Health Literacy Educational Training to Support Older Patients With Type II Diabetes

The JACARDI trial is a multicenter study involving an educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes.

ClinicalTrials.gov IDNCT06904690

PhaseNA

Enrollment200

SponsorIstituto Nazionale di Ricovero e Cura per Anziani

Age60 Years

SexALL

I'm interested View official listing

Conditions studied

Type 2 Diabetes

About this study

The JACARDI trial is a multicenter study involving an educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes.

Interventions

Other: Educational training — The educational training is divided into the following five modules: Module 1: Raising Awareness of eHealth and Health Literacy (Introduction to the aims and context of JACARDI and diabetes); Module 2: Acquiring New Knowledge (Health Literacy and Self-Management of Diabetes); Module 3: Acquiring New Knowledge (Technological and Non-Technological Strategies to Support the Self-Management of Diabetes); Module 4: Practicing New Skills (Usability with Practice Sessions); Module 5: Self-Evaluation and Sustainability of Improvement (Final Questionnaire). The training will be conducted over 10 weeks (one session every other week), with each session lasting an average of 90 minutes.

Primary outcomes

eHealth literacy (Baseline and 10, 14 and 34 weeks later)

Eligibility information

Inclusion Criteria: * Low eHealth literacy (eHeals scale ≤ 29) * No acute or untreated medical problems * Mini Mental State Examination (MMSE) ≥ 24 * Geriatric Depression Scale (GDS) \< 2 Exclusion Criteria: * A myocardial infarction or stroke within 6 months * Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility * Uncontrolled hypertension * Advanced Parkinson's disease or other neuromuscular disorder * Metastatic cancer or immunosuppressive therapy * Significant visual or hearing impairment

Study locations

AOU Ospedaliera Marche, Ancona, 60127 Italy
IRCCS INRCA Hospital, Ancona, 60127 Italy

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.